TytoCare × ALERUNO — Non-Clinical Release Effect Assurance

Software/device workflow assurance without touching clinical decisions or patient data

Why this maps to TytoCare now

TytoCare is expanding an AI-first clinical enablement platform and emphasizes integrated care workflows, regulated software, real-world performance monitoring and continuous oversight.

Strict non-clinical demo boundary

  • No diagnosis, treatment recommendation or medical decision.
  • No patient data.
  • Only software/release/integration evidence in a synthetic environment.

Synthetic demo

  1. Define expected release/integration state.
  2. Check authorized deployment scope.
  3. Simulate release or configuration change.
  4. Independent observer verifies actual version/configuration.
  5. Revoke/rollback scenario verifies closure.
  6. Generate immutable release-effect receipt.

Starter pilot

One bounded release/integration workflow, synthetic or read-only. Existing indicative early-adopter fee: ₪7,500, subject to final scope.
ALERUNO EffectProof — synthetic / non-production demo. No customer production data used.